Watch Ticker

Pliant Therapeutics, Inc. Common Stock

Go to Pliant Therapeutics, Inc. Common Stock Website

$1.72

0.02 (1.14%)

Live

Previous Close

$1.73

Day Range

$1.61 - $1.75

Previous Day Range

$1.565 - $1.79

Market Cap

$104.4 million USD

Day Vol.

797258

Previous Day Vol.

1.4 million

Currency

USD

Primary Exchange

Nasdaq

Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small m...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

N/A - INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Pliant Therapeutics

Pliant Therapeutics has voluntarily paused enrollment and dosing in its ongoing BEACON-IPF Phase 2b trial of bexotegrast, leading to a significant drop in its stock price. Faruqi & Faruqi, LLP is investigating potential claims on behalf of investors who suffered significant losses.

Related tickers: PLRX.

Read Full Article

N/A - Pliant Therapeutics Provides Update on BEACON-IPF, a Phase 2b/3 Trial in Patients with Idiopathic Pulmonary Fibrosis

Pliant Therapeutics has voluntarily paused enrollment and dosing in the ongoing BEACON-IPF Phase 2b trial of bexotegrast for idiopathic pulmonary fibrosis, following a recommendation by the trial's independent Data Safety Monitoring Board. The company will monitor current patients while the data is reviewed.

Related tickers: PLRX.

Read Full Article

Trending Tickers

Please sign in to view